The global melasma drug treatment market is witnessing steady growth as awareness around skin health and cosmetic dermatology continues to rise. Valued at US$ 2.6 Bn in 2022, the market is projected to surpass US$ 5.2 Bn by 2031, expanding at a CAGR of 8.3% during the forecast period. Increasing prevalence of melasma, particularly among women, along with advancements in treatment technologies,...